Insulin-related amyloidosis, or injection-localized amyloidosis, is a rare condition that occurs in diabetic patients who do not alter the site of insulin injection. In such cases, insulin aggregates and forms subcutaneous amyloid at the site of the injection. The condition is not considered dangerous systemically and the amyloid can be removed surgically.